KLF14/miR‐1283/TFAP2C axis inhibits HER2‐positive breast cancer progression via declining tumor cell proliferation

Abstract

AbstractMiR‐1283 has been identified as a tumor suppressor in some malignancies. Whereas, the role of miR‐1283 in HER2‐positive (HER2+) breast cancer, particularly its role in regulating cell proliferation, one of the most significant features of tumor progression, is unclear. The related microRNA screened by the breast cancer sample GSE131599 dataset were detected in HER2+ breast cancer tissues and cell lines. Then, the obtained miR‐1283 was overexpressed in SKBR3 and BT‐474 cells followed by relevant functional assays concerning cell proliferation and apoptosis. The xenograft mouse model was induced and the effect of miR‐1283 on tumor growth and cell proliferation was examined. The target of miR‐1283 and the transcription factor regulating miR‐1283 were predicted and identified. Finally, the influence of transcription factor KLF14 on cell proliferation and apoptosis was investigated. An integrated analysis confirmed that miR‐1283 expression was significantly decreased in HER2+ breast cancer tissues. Also, by q‐RT‐PCR detection, miR‐1283 expression was markedly reduced in HER2+ breast cancer tissues and cell lines. The miR‐1283 overexpression prevented the proliferation and enhanced apoptosis of HER2+ breast cancer cells, as well as inhibited tumor growth. Mechanistically, miR‐1283 inhibited TFAP2C expression by targeting the 3′‐untranslated regions of TFAP2C messenger RNA, and the KLF14 enhanced miR‐1283 level via binding to its promoter. The result subsequently confirmed the KLF14/miR‐1283 signaling suppressed cell proliferation in HER2+ breast cancer. Our results suggested that the KLF14/miR‐1283/TFAP2C axis inhibited HER2+ breast cancer progression, which might provide novel insight into mechanical exploration for this disease.